BEST UNLIMITED TURBO SHORT CERTIFICATE - IPSEN | Market Closed - Euronext Paris 17:30:00 17/05/2024 BST | ||
| 0.675 EUR | +6.30% |
|
| Current month | -32.84% | ||
| 1 month | -51.61% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
| Date | Price | Change |
|---|---|---|
| 17/05/24 | 0.675 | +6.30% |
| 16/05/24 | 0.635 | -3.05% |
| 15/05/24 | 0.655 | +4.80% |
| 14/05/24 | 0.625 | -18.30% |
| 13/05/24 | 0.765 | +4.08% |
Real-time Euronext Paris
Last update May 17, 2024 at 05:30 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | IPSEN |
| Issuer | 
Société Générale
|
| 7N84S | |
| ISIN | DE000SH7ZJF2 |
| Date issued | 24/03/2022 |
| Strike | 133.7 € |
| Maturity | Unlimited |
| Parity | 20 : 1 |
| Emission price | 1.69 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.075 € |
|---|---|
| Lowest since issue | 0.215 € |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
120.8
EUR
Average target price
126.3
EUR
Spread / Average Target
+4.58%
- Stock Market
- Certificates
- 7N84S Certificat
